SAREPTA THERAPEUTICS, INC. Warrants Not Settleable in Cash, Fair Value Disclosure
SAREPTA THERAPEUTICS, INC. (SRPT) had Warrants Not Settleable in Cash, Fair Value Disclosure of $9.83 million as of 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2015-02-26
- 2014-06-30: Warrants Not Settleable in Cash, Fair Value Disclosure $9.83M.
- 2014-03-31: Warrants Not Settleable in Cash, Fair Value Disclosure $9.21M.
- 2013-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $9.01M.
- 2012-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $65.19M.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2014-06-30 | $9.83M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $9.21M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $9.01M 10-K · filed 2015-02-26 |
| 2012-12-31 | $65.19M 10-K · filed 2015-02-26 |
| 2011-12-31 | $5.45M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |